The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Serum and glucocorticoid‐regulated protein kinases: Variations on a theme
Abstract
The phosphatidylinositol 3′ kinase (PI3K)‐signaling pathway plays a critical role in a variety of cellular responses such as modulation of cell survival, glucose homeostasis, cell division, and cell growth. PI3K generates important lipid second messengers—phosphatidylinositides that are phosphorylated at the 3′ position of their inositol ring head‐group. These membrane restricted lipids act by binding with high affinity to specific protein domains such as the pleckstrin homology (PH) domain. Effectors of PI3K include molecules that harbor such domains such as phosphoinositide‐dependent kinase (PDK1) and protein kinase B (PKB), also termed Akt. The mammalian genome encodes three different PKB genes (α, β, and γ; Akt1, 2, and 3, respectively) and each is an attractive target for therapeutic intervention in diseases such as glioblastoma and breast cancer. A second family of three protein kinases, termed serum and glucocorticoid‐regulated protein kinases (SGKs), is structurally related to the PKB family including regulation by PI3K but lack a PH domain. However, in addition to PH domains, a second class of 3′ phosphorylated inositol phospholipid‐binding domains exists that is termed Phox homology (PX) domain: this domain is found in one of the SGKs (SGK3). Here, we summarize knowledge of the three SGK isoforms and compare and contrast them to PKB with respect to their possible importance in cellular regulation and potential as therapeutic targets. J. Cell. Biochem. © 2006 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216
The phosphoinositide 3-kinase pathway
Cantley, L. C. (2002) · Science · doi:10.1126/science.296.5573.1655 · Cited by 5,621
Brunet, A., Park, J., Tran, H., Hu, L. S., Hemmings, B. A., & Greenberg, M. E. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.3.952-965.2001 · Cited by 860
KOBAYASHI, T., DEAK, M., MORRICE, N., & COHEN, P. (1999) · Biochemical Journal · doi:10.1042/bj3440189 · Cited by 405
Ubiquitin modification of serum and glucocorticoid-induced protein kinase-1 (SGK-1)
Brickley, D. R., Mikosz, C. A., Hagan, C. R., & Conzen, S. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207604200 · Cited by 94
Chun, J., Kwon, T., Lee, E. J., Kim, C. H., Han, Y. S., Hong, S.-K., Hyun, S., & Kang, S. S. (2004) · Molecules and Cells · doi:10.1016/s1016-8478(23)13125-6 · Cited by 73
sgk1, a member of an RNA cluster associated with cell death in a model of Parkinson's disease
Stichel, C. C., Schoenebeck, B., Foguet, M., Siebertz, B., Bader, V., Zhu, X. R., & Lübbert, H. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.03859.x · Cited by 43
Imai, S., Okayama, N., Shimizu, M., & Itoh, M. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00092-4 · Cited by 32
Cited by
Tzschentke, T. M. (2007) · Addiction Biology · doi:10.1111/j.1369-1600.2007.00070.x · Cited by 1,336
Peterson, T. R., Laplante, M., Thoreen, C. C., Sancak, Y., Kang, S. A., Kuehl, W. M., Gray, N. S., & Sabatini, D. M. (2009) · Cell · doi:10.1016/j.cell.2009.03.046 · Cited by 1,202
García-Martínez, J. M., & Alessi, D. R. (2008) · Biochemical Journal · doi:10.1042/bj20081668 · Cited by 907
The PI3K-AKT-mTOR Pathway and Prostate Cancer: At the Crossroads of AR, MAPK, and WNT Signaling
Shorning, B. Y., Dass, M. S., Smalley, M. J., & Pearson, H. B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124507 · Cited by 616
Neuroplasticity in the mesolimbic dopamine system and cocaine addiction
Thomas, M. J., Kalivas, P. W., & Shaham, Y. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.77 · Cited by 516
Valjent, E., Pagès, C., Hervé, D., Girault, J., & Caboche, J. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03278.x · Cited by 438
Wander, S. A., Hennessy, B. T., & Slingerland, J. M. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44145 · Cited by 427
mTOR Complex 2 Is Required for the Development of Prostate Cancer Induced by Pten Loss in Mice
Guertin, D. A., Stevens, D. M., Saitoh, M., Kinkel, S., Crosby, K., Sheen, J.-H., Mullholland, D. J., Magnuson, M. A., Wu, H., & Sabatini, D. M. (2009) · Cancer Cell · doi:10.1016/j.ccr.2008.12.017 · Cited by 355
Pharmacological PKA Inhibition: All May Not Be What It Seems
Murray, A. J. (2008) · Science Signaling · doi:10.1126/scisignal.122re4 · Cited by 327
Behavioural and biochemical evidence for interactions between Δ9‐tetrahydrocannabinol and nicotine
Valjent, E., Mitchell, J. M., Besson, M., Caboche, J., & Maldonado, R. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704479 · Cited by 321
Targeting mTOR: prospects for mTOR complex 2 inhibitors in cancer therapy
Sparks, C. A., & Guertin, D. A. (2010) · Oncogene · doi:10.1038/onc.2010.139 · Cited by 299
Crosstalk between circRNAs and the PI3K/AKT signaling pathway in cancer progression
Xue, C., Li, G., Lu, J., & Li, L. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00788-w · Cited by 268
mTOR-Raptor Binds and Activates SGK1 to Regulate p27 Phosphorylation
Hong, F., Larrea, M. D., Doughty, C., Kwiatkowski, D. J., Squillace, R., & Slingerland, J. M. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.04.027 · Cited by 260
The Insulin/Akt Signaling Pathway Is Targeted by Intracellular β-Amyloid
Lee, H.-K., Kumar, P., Fu, Q., Rosen, K. M., & Querfurth, H. W. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-07-0777 · Cited by 185
In vivo nicotine treatment regulates mesocorticolimbic CREB and ERK signaling in C57Bl/6J mice
Brunzell, D. H., Russell, D. S., & Picciotto, M. R. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01640.x · Cited by 176
mTOR complex 1: a key player in neuroadaptations induced by drugs of abuse
Neasta, J., Barak, S., Hamida, S. B., & Ron, D. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12725 · Cited by 114
Zhu, C., Wang, S., Wang, B., Du, F., Hu, C., Li, H., Feng, Y., Zhu, R., Mo, M., Cao, Y., et al. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.07.057 · Cited by 76
Shin, S. H., Lee, E. J., Hyun, S., Chun, J., Kim, Y., & Kang, S. S. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2011.11.002 · Cited by 63
Zhou, H., Gao, S., Duan, X., Liang, S., Scott, D. A., Lamont, R. J., & Wang, H. (2015) · The FASEB Journal · doi:10.1096/fj.15-270462 · Cited by 40
Ferrelli, F., Pastore, D., Capuani, B., Lombardo, M. F., Blot-Chabaud, M., Coppola, A., Basello, K., Galli, A., Donadel, G., Romano, M., et al. (2015) · Acta Diabetologica · doi:10.1007/s00592-014-0600-4 · Cited by 30
Sheng, H., Sun, T., Cong, B., He, P., Zhang, Y., Yan, J., Lu, C., & Ni, X. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90462.2008 · Cited by 21
Metadata
- Authors
- Tessier, M., & Woodgett, J. R.
- Venue
- Journal of Cellular Biochemistry
- Publisher
- Wiley
- Published
- 2006-04-17
- Volume
- 98
- Issue
- 6
- Pages
- 1391-1407
- ISSN
- 0730-2312 (ISSN-L)
- 1097-4644
- OpenAlex
- W2006676086
- Cited by
- 177
- References
- 8
- FWCI
- 6.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.